Warren Sobol, MD
Retina Specialist · Cleveland, OHNPI 1881691327
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Alimera Sciences, Inc. at 53.5% of the total. Reporting peaked in 2022 at $2,590 and has fallen 81.6% since, to $477 in 2025.
Across 96 payments — averaging $50.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alimera Sciences, Inc.$3K
- Regeneron Healthcare Solutions, Inc.$352
- AbbVie$285
- Apellis Pharmaceuticals, Inc.$261
- Genentech USA, Inc.$241
- Eyepoint US, Inc.$234
- plus $892 from 12 others
What the payments were for
- Speaking & faculty fees$2,40049%
- Food & beverage$2,47051%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alimera Sciences, Inc. | 14 | $2,604 |
| Regeneron Healthcare Solutions, Inc. | 16 | $352 |
| AbbVie(2 entities) | 11 | $285 |
| Apellis Pharmaceuticals, Inc. | 16 | $261 |
| Genentech USA, Inc. | 9 | $241 |
| Eyepoint US, Inc. | 4 | $234 |
| Sandoz | 4 | $208 |
| Coherus Oncology, Inc. | 3 | $156 |
| Mallinckrodt Hospital Products Inc. | 1 | $127 |
| Astellas Pharma US Inc | 4 | $105 |
| Amgen | 4 | $79 |
| Regeneron | 2 | $47 |
| Halozyme Inc | 2 | $45 |
| Harrow Eye, LLC | 2 | $32 |
| Topcon Healthcare, Inc. | 1 | $29 |
| Spark Therapeutics, Inc. | 1 | $24 |
| Bausch & Lomb Americas Inc. | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,870 in reported general payments places this provider in the 55th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 50 | $2,667 |
| Brimonidine Tartrate | 15 | $204 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Cleveland
- Sumit SharmaCleveland$428K
- Aleksandra RachitskayaCleveland$303K
- Katherine TalcottCleveland$272K
- Suber HuangCleveland$124K
- Ananth SastryCleveland$44K
- Phoebe LinCleveland$22K
- Mark SeralyCleveland$3K
- Abhishek NaiduCleveland$3K
- Mary-Grace ReevesCleveland$2K
- Joseph ConeyBeachwood$980K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.